达芬奇机器人手术系统在肝门部胆管癌根治术中的应用价值

来源 :中华消化外科杂志 | 被引量 : 0次 | 上传用户:buugly
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨达芬奇机器人手术系统在肝门部胆管癌(pCCA)根治术中的应用价值。方法:采用回顾性描述性研究方法。收集2018年9月至2021年3月华中科技大学同济医学院附属协和医院收治的10例行达芬奇机器人手术系统pCCA根治术患者的临床病理资料;男6例,女4例;年龄为(58±7)岁。观察指标:(1)手术情况。(2)术后情况。(3)随访情况。采用电话和门诊方式进行随访,了解患者生存情况和肿瘤复发情况。随访时间截至2021年6月。正态分布的计量资料以n x±s表示。偏态分布的计量资料以n M(范围)表示。计数资料以绝对数表示。n 结果:(1)手术情况:10例患者均顺利完成达芬奇机器人手术系统pCCA根治术,无中转开腹和术中输血患者。10例患者手术时间为(465±87)min,术中出血量为(167±81)mL。10例患者中,1例Bismuth Ⅲb型手术标本切缘阳性,9例为Rn 0切除。(2)术后情况:10例患者胃管拔除时间为(2.3±1.9)d,术后住院时间为(19.9±9.0)d。10例患者中,无二次手术和围手术期死亡。10例患者中,6例发生围手术期并发症,其中5例发生胸腔积液,3例发生腹腔积液,1例发生肠梗阻,部分患者合并多种并发症。上述并发症经对症保守治疗后,患者胸腔积液、腹腔积液消失,肠梗阻好转。10例患者术后均未发生出血、胆瘘、肠瘘等严重并发症。(3)随访情况:10例患者均获得随访,随访时间为3~20个月,中位随访时间为11个月。随访期间,10例患者中,3例肿瘤复发,复发位置为残肝肝内胆管,腹腔其余位置未发生种植转移。7例肿瘤未复发患者中,1例因消化道出血、多器官功能衰竭死亡。10例患者中,9例生存。n 结论:达芬奇机器人手术系统用于pCCA根治术可行。“,”Objective:To investigate the application value of Da Vinci robotic surgical system in radical resection of perihilar cholangiocarcinoma (pCCA).Methods:The retrospective and descrip-tive study was conducted. The clinicopathological data of 10 patients undergoing Da Vinci robotic radical resetion of pCCA in Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from September 2018 to March 2021 were collected. There were 6 males and 4 females, aged (58±7)years. Observtaion indicators: (1) surgical situations; (2) postoperative situations; (3) follow-up. The patients were followed up by telephone interview and outpatient service to detect survival of patients and tumor recurrence up to June 2021. Measurement data with normal distribution were expressed as n Mean±n SD, and measurement data with skewed distribu-tion were represented as n M(range). Count data were represented as absolute numbers.n Results:(1) Surgical situations: 10 patients underwent Da Vinci robotic radical resection of pCCA succe-ssfully, without conversion to laparotomy or intraoperative blood transfusion. The operation time of 10 patients was (465±87)minutes, and the volume of intraoperative blood loss was (167±81)mL. Of the 10 patients, 1 case of Bismuth type Ⅲb had a positive surgical margin and the remaining 9 cases had Rn 0 resection. (2) Postoperative situations: the time to gastric tube extraction was (2.3±1.9)days, and the duration of postoperative hospital stay of the 10 patients was (19.9±9.0)days. Among the 10 patients, there was no second operation or perioperative death. Of the 10 patients, 6 cases had perioperative complications, including 5 cases wth pleural effusion, 3 cases with peritoneal effusion, and 1 case with intestinal obstruction, some patients had multiple complications. After symptomatic conservative treatment, pleural effusion and peritoneal effusion disappeared and intestinal obstruction was improved. None of the 10 patients had serious complica-tions such as bleeding, biliary fistula or intestinal fistula. (3) Follow-up: 10 patients were followed up for 3-20 months, with a median follow-up time of 11 months. During the follow-up, 3 of 10 patients had tumor recurrence which occurred in intrahepatic bile duct of residual liver, and no implantation metastasis was found in the rest of abdominal cavity. Of the 7 unrecurrent patients, 1 case died of gastrointestinal bleeding and multiple organ failure. Nine of 10 patients survived well.n Conclusion:The Da Vinci robotic surgical system used for radical operation of pCCA is feasible.
其他文献
胆道外科的历史源远流长。自文艺复兴时期以来,无数前辈从认识胆道开始,由胆囊切除发展到肝外胆管探查,取得显著进步。黄志强院士首次采用肝叶切除治疗复杂肝胆管结石病,将胆道外科从肝外胆管发展到肝内胆管。精准胆道外科技术体系的建立与成熟,标志着胆道外科迈入“段”的时代。然而,由于诊断与治疗全流程中理念与技术的诸多不确定性,胆道外科仍然是目前腹部外科最复杂,预后亟需改善的领域之一。未来的胆道外科将突破现有的肝段水平,通过与各领域的专家合作,作出基于大数据、人工智能背景的医疗决策并开展更加精准的手术作业。笔者通过回顾
高科技促使外科领域飞速发展,各种高新技术层出不穷,患者及医师均受益良多,同时也出现不可回避的问题,其实不足为奇。任何事情都需一分为二看待,可称之为“双刃剑”作用。谈及此问题、重视此问题,是为促使高科技在外科领域更好地应用。“,”High technology promotes the rapid development of the surgery. Various high and new technologies emerge to benefit patients and doctors. Howe
胰腺外科是普通外科领域的重要专科。胰腺因位置深在,解剖结构复杂,且胰腺外科涉及病种较多,病情严重,手术难度高,既往发展缓慢。近20年来,随着对相关领域基础和临床研究的深入,研究者对胰腺疾病的认知逐渐加深,且将一系列新理念、新技术应用于胰腺外科中,使胰腺外科进入快速发展阶段。同时,研究者也认识到,现有的医疗理念和技术手段并不足以解决所有临床问题。只有把握机遇,不断探索、勇于创新,才能使我国胰腺外科事业保持活力,蓬勃发展。“,”Pancreatic surgery is an important specia
自《中华消化外科杂志》(以下简称杂志)创立以来,一代代专家与杂志共同成长,共同进步。在2017年11月,杂志成立第一届“中华消化外科菁英荟”,笔者有幸成为结直肠外科学组委员,在组长姚宏伟教授的带领下,围绕结直肠外科的热点开展热烈的学术讨论与思辨。时光荏苒,岁月如梭,近年来,笔者也承担了杂志的审稿工作。在审阅稿件的过程中了解同道发表的精彩研究与消化外科领域的最新进展,自己也大有裨益,收获良多,并有幸荣获2次优秀审稿专家的称号。随着杂志的飞速发展,笔者也逐渐在传媒与教育领域开辟出新的方向。不但在自媒体平台开设
期刊
期刊
期刊
期刊
在临床研究过程中处理分析的医疗数据包含大量患者个人信息,因此,临床研究人员在临床研究中应做好医疗数据安全管理工作。2021年9月1日和11月1日相继正式实施的《中华人民共和国数据安全法》和《中华人民共和国个人信息保护法》为我国数据安全和个人信息保护提供了法律依据,为医疗数据的安全使用指明方向,这标志着数据治理进入“强监管时代”。在临床研究的医疗数据收集及应用过程中尊重保护患者隐私安全,保障医疗数据质量,安全管理医疗数据并开展高质量临床研究,将是在新的法律背景下临床科研数据收集和应用的重要考量。“,”The
期刊